Abstract
Background
Multiple sclerosis (MS) is frequently associated with depressive symptoms and major depression.
Objective
We assessed psychometric properties of the Hamilton Depression Rating Scale (HDRS, 17-item version) for assessing depressive symptomatology in a sample of MS patients.
Methods
Seventy patients (aged 43.3 ± 10.3 years) completed the HDRS and a thorough clinical and neuropsychological assessment, including diagnosis of major depression according to the established clinical criteria.
Results
HDRS was easy to administer and acceptable, and showed fair internal consistency (Cronbach’s alpha = 0.8). The HDRS showed good convergent validity with respect to neuropsychiatric inventory (NPI) subdomain of depression (r rho = .85) and good divergent validity with respect to remaining NPI subdomains (r rho < .30). Moreover, HDRS’s total score correlated moderately with functional disability and apathetic symptomatology, and poorly with general cognitive status. Receiver operating characteristics curve analysis demonstrated that a cutoff >14.5 can identify clinically relevant depressive symptoms with good sensitivity (93 %) and specificity (97 %) with respect to the diagnosis of major depression. Such a cutoff identified clinically relevant depressive symptoms in 42 % of our MS sample, whereas 44.2 % patients met established clinical criteria for major depression.
Conclusion
The HDRS can be considered as an easy, reliable, and valid tool to assess depressive symptomatology for clinical and research purposes in non-demented MS patients.
Similar content being viewed by others
References
Feinstein, A., Magalhaes, S., Richard, J. F., Audet, B., & Moore, C. (2014). The link between multiple sclerosis and depression. Nat Rev Neurol, 10(9), 507–517.
Minden, S. L., Orav, J., & Reich, P. (1987). Depression in multiple sclerosis. General Hospital Psychiatry, 9, 4–434.
Sadovnick, A. D., Remick, R. A., Allen, J., et al. (1996). Depression and multiple sclerosis. Neurology, 46, 628–632.
Benedict, R. H., Fishman, I., McClellan, M. M., Bakshi, R., & Weinstock-Guttman, B. (2003). Validity of the beck depression inventory-fast screen in multiple sclerosis. Mult Scler, 9(4), 393–396.
Wood, B., van der Mei, I. A., Ponsonby, A. L., Pittas, F., Quinn, S., Dwyer, T., et al. (2013). Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler, 19(2), 217–224.
Schiffer, R. B. (1990). Disturbances of affect. In S. M. Rao (Ed.), Neurobehavioral aspects of multiple sclerosis (pp. 186–195). New York: Oxford University Press.
Siegert, R. J., & Abernethy, D. A. (2005). Depression in multiple sclerosis: a review. Journal of Neurology, Neurosurgery and Psychiatry, 76, 469–475.
Mohr, D. C., Goodkin, D. E., Gatto, N., & Van Der Wende, J. (1997). Depression, coping and level of neurological impairment in multiple sclerosis. Mult Scler, 3, 254–258.
Benito-León, J., Morales, J. M., & Rivera-Navarro, J. (2002). Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. European Journal of Neurology, 9(5), 497–502.
Amato, M. P., Ponziani, G., Rossi, F., Liedl, C. L., Stefanile, C., & Rossi, L. (2001). Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler, 7, 340–344.
Gilchrist, A. C., & Creed, F. H. (1994). Depression, cognitive impairment and social stress in multiple sclerosis. Journal of Psychosomatic Research, 38, 193–201.
Feinstein, A. (2002). An examination of suicidal intent in patients with multiple sclerosis. Neurology, 59(5), 674–678.
Goodkin, D. E. (1992). The natural history of multiple sclerosis. In R. A. Rudick & G. E. Goodkin (Eds.), Treatment of multiple sclerosis: trial design, results, and future perspectives (pp. 17–46). New York: Springer-Verlag.
Cassem, E. H. (1995). Depressive disorders in the medically ill: an overview. Psychosomatics, 36, 2–10.
Patten, S. (2010). Diagnosing depression in MS in the face of overlapping symptoms. Int MS J, 17(1), 3–5.
Cuijpers, P., Li, J., Hofmann, S. G., & Andersson, G. (2010). Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: a meta-analysis. Clinical Psychology Review, 30(6), 768–778.
Hamilton, M. (1960). A rating scale for depression. J Neurol Neurosurg Psychiatr, 23, 56–62.
Broen, M. P., Moonen, A. J., Kuijf, M. L., Dujardin, K., Marsh, L., Richard, I. H., et al. (2015). Factor analysis of the Hamilton Depression Rating Scale in Parkinson’s disease. Parkinsonism Relat Disord, 3(2), 142–146.
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004). The Hamilton Depression Rating Scale: has the gold standard become a lead weight? American Journal of Psychiatry, 161(12), 2163–2177.
Shafer, A. B. (2006). Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. Journal of Clinical Psychology, 62(1), 123–146.
Moran, P. J., & Mohr, D. C. (2005). The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis. Journal of Behavioral Medicine, 28(1), 35–41.
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., et al. (2011). Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annu Neurol, 69(2), 292–302.
American Psychiatric Association. (2002). Diagnostic and statistical manual of mental disorders, 4th edition, text revised. Washington: American Psychiatric Association.
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198.
Measso, G., Cavarzeran, F., Zappalà, C., Lebowitz, B. D., Crook, T. H., & Pirozzolo, F. J. (1993). The Mini-mental state examination. Normative study of an Italian random sample. Dev Neuropsychol, 9, 77–85.
Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 33(11), 1444–1452.
Bertolucci, P. H., Brucki, S. M., Campacci, S. R., & Juliano, Y. (1994). The mini-mental state examination in a general population: impact of educational status. Arquivos de Neuro-Psiquiatria, 52(1), 1–7.
Grut, M., Fratiglioni, L., Viitanen, M., & Winblad, B. (1993). Accuracy of the mini-mental status examination as a screening test for dementia in a Swedish elderly population. Acta Neurologica Scandinavica, 87(4), 312–317.
Marin, R. S., Biedrzycki, R. C., & Firingiogullari, S. (1991). Reliability and validity of the Apathy Evaluation Scale. Psychiatry Research, 38, 143–162.
Raimo, S., Trojano, L., Spitaleri, D. L. A., Petretta, V., Grossi, D., & Santangelo, G. (2014). Apathy in multiple sclerosis: a validation study of the Apathy Evaluation Scale. Journal of the Neurological Sciences, 347(1–2), 295–300.
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44(12), 2308–2314.
Cummings, J. L. (1997). The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology, 48, S10–S16.
McHorney, C. A., & Tarlov, A. R. (1995). Individual-patient monitoring in clinical practice: are available health surveys adequate? Quality of Life Research, 4, 293–307.
Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.
Scientific Advisory Committee of the Medical Outcomes Trust. (2002). Assessing health status and quality-of-life instruments: attributes and review criteria. Quality of Life Research, 11, 193–205.
Carlson, K. D., & Herdman, A. (2012). Understanding the impact of convergent validity on research results. Organ Res Methods, 15(1), 17–32.
Cohen, J. W. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: Laurence Erlbaum Associates.
Trajković, G., Starčević, V., Latas, M., Leštarević, M., Ille, T., Bukumirić, Z., & Marinković, J. (2011). Reliability of the Hamilton Rating Scale for Depression: a meta-analysis over a period of 49 years. Psychiatry Research, 189(1), 1–9.
Starkstein, S. E., Ingram, L., Garau, M. L., & Mizrahi, R. (2005). On the overlap between apathy and depression in dementia. Journal of Neurology, Neurosurgery and Psychiatry, 76(8), 1070–1074.
Marin, R. S., Firinciogullari, S., & Biedrzycki, R. C. (1993). The sources of convergence between measures of apathy and depression. Journal of Affective Disorders, 28(1), 7–14.
Lynch, S. G., Kroencke, D. C., & Denney, D. R. (2001). The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope. Mult Scler, 7(6), 411–416.
Niino, M., Mifune, N., Kohriyama, T., Mori, M., Ohashi, T., Kawachi, I., et al. (2014). Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis. BMC Neurol, 14, 3.
Devins, G. M., Seland, T. P., Klein, G., Edworthy, S. M., & Saary, M. J. (1993). Stability and determinants of psychosocial well-being in multiple sclerosis. Rehabil Psychol, 38(1), 11–26.
Bakshi, R., Thompson, A. J., Rocca, M. A., Pelletier, D., Dousset, V., Barkhof, F., et al. (2008). MRI in multiple sclerosis: current status and future prospects. Lancet Neurology, 7(7), 615–625.
Weinstock-Guttman, B., Ransohoff, R. M., Kinkel, R. P., & Rudick, R. A. (1995). The interferons: biological effects, mechanisms of action, and use in multiple sclerosis. Annu Neurol, 37(1), 7–15.
Filippini, G., Brusaferri, F., Sibley, WA., Citterio, A., Ciucci, G., Midgard, R., Candelise, L. (2000). Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. Cochrane Database Syst Rev, (4), CD001331.
Pompili, M., Forte, A., Palermo, M., Stefani, H., Lamis, D. A., Serafini, G., et al. (2012). Suicide risk in multiple sclerosis: a systematic review of current literature. Journal of Psychosomatic Research, 73(6), 411–417.
Rickards, H. (2006). Depression in neurological disorders: an update. Curr Opin Psychiatry, 19(3), 294–298.
Leentjens, A. F., Marinus, J., Van Hilten, J. J., Lousberg, R., & Verhey, F. R. (2003). The contribution of somatic symptoms to the diagnosis of depressive disorder in Parkinson’s disease: a discriminant analytic approach. Journal of Neuropsychiatry and Clinical Neurosciences, 15(1), 74–77.
Cummings, J. L. (1992). Depression and Parkinson’s disease: a review. American Journal of Psychiatry, 149, 443–454.
Kummer, A., Cardoso, F., & Teixeira, A. L. (2009). Suicidal ideation in Parkinson’s disease. CNS Spectrums, 14(8), 431–436.
Stanton, B. R., Barnes, F., & Silber, E. (2006). Sleep and fatigue in multiple sclerosis. Mult Scler, 12, 481–486.
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008). Clinical guideline for the evaluation and management of chronic insomnia in adults. Journal of Clinical Sleep Medicine, 4, 487–504.
Johnson, E. O., Roth, T., & Breslau, N. (2006). The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. Journal of Psychiatric Research, 40(8), 700–708.
Schrag, A., Barone, P., Brown, R. G., Leentjens, A. F., McDonald, W. M., Starkstein, S., et al. (2007). Depression rating scales in Parkinson’s disease: critique and recommendations. Movement Disorders, 22(8), 1077–1092.
Zimmerman, M., Martinez, J. H., Young, D., Chelminski, I., & Dalrymple, K. (2013). Severity classification on the Hamilton Depression Rating Scale. Journal of Affective Disorders, 150(2), 384–388.
Naarding, P., Leentjens, A. F., van Kooten, F., & Verhey, F. R. (2002). Disease-specific properties of the Rating Scale for depression in patients with stroke, Alzheimer’s dementia, and Parkinson’s disease. Journal of Neuropsychiatry and Clinical Neurosciences, 14(3), 329–334.
Weintraub, D., Oehlberg, K. A., Katz, I. R., & Stern, M. B. (2006). Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry, 14(2), 169–175.
Uher, R., Perlis, R. H., Placentino, A., Dernovšek, M. Z., Henigsberg, N., Mors, O., et al. (2012). Self-report and clinician-rated measures of depression severity: can one replace the other? Depression and Anxiety, 29(12), 1043–1049.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Standard
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the Declaration of Helsinki 1964 and was approved by the local ethics committee.
Informed consent was obtained from all individual participants included in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Raimo, S., Trojano, L., Spitaleri, D. et al. Psychometric properties of the Hamilton Depression Rating Scale in multiple sclerosis. Qual Life Res 24, 1973–1980 (2015). https://doi.org/10.1007/s11136-015-0940-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-015-0940-8